Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Providence, Rhode Island 02903


Purpose:

The purpose of this study is to demonstrate the safety and effectiveness of the T2Bacteria Panel by validating the clinical performance (i.e. estimated sensitivity and specificity) of the T2Bacteria Panel compared to blood culture results and/or known Bacteria positive status of prospectively collected clinical specimens and contrived (i.e. Bacteria-spiked) whole blood "clinical samples".


Criteria:

Inclusion Criteria: - Subject or subject's legally authorized representative (LAR) must be able to understand, read and sign the study specific informed consent form after the nature of the study has been fully explained to them. - Subject has had a diagnostic blood culture ordered, per routine standard of care (prospective arm only). - Subject is between 18-95 years of age. Exclusion Criteria: - Subject has other co-morbid condition(s) that, in the opinion of the Investigator, could limit the subject's ability to participate in the study or impact the scientific integrity of the study. - Subject has had previous specimens tested by the T2Bacteria Panel with valid results. - Treatment of subject with any investigational novel drug compound within 30 days prior to the collection of T2 specimens.


NCT ID:

NCT02535468


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Providence, Rhode Island 02903
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.